Biogen and Eisai reported the finding from a large late-stage clinical trial of lecanemab, a drug they are developing.
#back #participants #chief-executive #press-release #tuesday-night #southern-california #side-effects #early-january #multibillion #alzheimers-disease
[
add
]
[
|
|
...
]